ArticleJournal of clinical orthopaedics and trauma2026
Fracture incidence in women with polycystic ovarian syndrome: A retrospective cohort analysis.
Article in Journal of clinical orthopaedics and trauma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic Ovarian Syndrome (PCOS) impacts reproductive-age women through metabolic disturbances and hormone imbalances. These changes have been linked to bone health, but the association between PCOS and incidence of fractures remains unclear. Clarifying the link between PCOS and fractures is important to guide clinical care and develop prevention strategies. Methods: A retrospective cohort analysis using the TriNetX research platform evaluated fracture incidence in female patients with and without PCOS. The study assessed the occurrence of distal radius, femoral neck, ankle, and metatarsal fractures, identified through ICD-10 codes. Fracture incidence was measured from one day following PCOS diagnosis to the most recent available encounter. Analysis was performed after propensity score matching, with statistical significance defined as a p-value of <0.05. Results: Final analysis included 174,937 patients in both cohorts. Incidence rates of distal radius, femoral neck, and metatarsal fractures were significantly reduced in patients with PCOS, with risk ratios of 0.7 (CI: 0.613-0.8), 0.647 (CI: 0.521-0.804), and 0.913 (CI: 0.834-0.998), respectively. Although the incidence rate of ankle fractures was also reduced in the PCOS cohort, this finding was not statistically significant (RR: 0.921, CI: 0.836-1.015). Conclusion: The results of this study show that patients with PCOS have lower distal radius, femoral neck, and metatarsal fracture rates compared to patients without PCOS. These findings suggest PCOS is not related to an increase in the risk of fractures. Further investigation is needed to better understand this potentially fracture-protective effect across different bone sites.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.